Tirzepatide use is associated with a lower incidence of new or progressive diabetic retinopathy (DR) and fewer complications.

STOCKHOLM — At the American Society of Retina Specialists (ASRS) 2024 Annual Meeting, researchers discussed how insights into potential risk factors and new treatments could improve outcomes for ...

Please provide your email address to receive an email when new articles are posted on . APX3330 is an oral, small-molecule Ref-1 inhibitor being developed for treating diabetic retinopathy. It reduced ...

Individuals with a dementia diagnosis before diabetes and those with macular edema were excluded, strengthening the temporal link between diabetes-related eye disease and later dementia risk. The ...

Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy.

Please provide your email address to receive an email when new articles are posted on . Significant differences in vessel density, foveal avascular zone area and RNFL thickness were reported between ...

STOCKHOLM -- The sodium glucose co-transporter 2 (SGLT2) class of diabetes medications may offer more protection against diabetic retinopathy as compared with other hypoglycemic agents, an analysis of ...

LONDON – Long-established, but often forgotten, primary care tools, including the swinging light test and the lipid-lowering drug fenofibrate, may help detect early worsening of diabetic retinopathy ...

Cataract surgery was associated with an increased risk of worsening diabetic retinopathy in adults with type 2 diabetes. Diabetes is a risk factor for complications due to cataract surgery. Patients ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...